Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|June 11, 2025
Long COVID-19 autoantibodies and their potential effect on fertilityLaura Talamini, Dennyson Leandro M Fonseca, Darja Kanduc, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2019
Oral vs Intravenous Antibiotics for Patients With Klebsiella pneumoniae Liver Abscess: A Randomized, Controlled Noninferiority StudyJames S Molton, Monica Chan, Shirin Kalimuddin, et al.Nature Microbiology|October 4, 2022
SARS-CoV-2 Omicron variant emerged under immune selectionChee Wah Tan, Wan Ni Chia, Feng Zhu, et al.Mbio|July 23, 2020
Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2Yvonne C F Su, Danielle E Anderson, Barnaby E Young, et al.Clinical Trials (London, England)|October 11, 2021
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.Plos One|June 18, 2025
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatmentElizabeth S Munroe, Greg A Grandits, Robert C Hyzy, et al.Ebiomedicine|April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational studyBarnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.American Journal of Respiratory and Critical Care Medicine|May 17, 2022
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess RecoveryDavid J Douin, Lianne Siegel, Greg Grandits, et al.Medrxiv : the Preprint Server for Health Sciences|November 20, 2020
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.Pageof 7